Last reviewed · How we verify

NCT04329208

Predictive Value of Mean Flow Velocity by TCD in Early Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

Completed Last updated 1 April 2020
What this trial tests

trial testing Transcranial doppler in Subarachnoid Hemorrhage in 40 participants. Completed in 1 February 2019.

Timeline
1 January 2018
Primary endpoint
1 January 2019
1 February 2019

Quick facts

Lead sponsorMansoura University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 January 2018
Primary completion1 January 2019
Estimated completion1 February 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University Hospital

Who can join

Adults 30 to 65, any sex, with Subarachnoid Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this work is to evaluate the transcranial doppler in prediction of cerebral vasospasm in aneurysmal subarachnoid hemorrhage and also to evaluate their advantages over clinical scales in predicting CV.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Transcranial Doppler for Early Prediction of Cognitive Impairment after Aneurysmal Subarachnoid Hemorrhage and the Associated Clinical Biomarkers.
    Esmael A, Belal T, Eltoukhy K. · · 2020 · cited 1× · PMID 33299539 · DOI 10.1155/2020/8874605

Verify or expand the search:

Other recruiting trials for Subarachnoid Hemorrhage

Currently open trials in the same condition.

Other Mansoura University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04329208.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing